WO2012091440A3 - Composition for improvement, treatment and prevention of gastrointestinal motility disorders - Google Patents

Composition for improvement, treatment and prevention of gastrointestinal motility disorders Download PDF

Info

Publication number
WO2012091440A3
WO2012091440A3 PCT/KR2011/010206 KR2011010206W WO2012091440A3 WO 2012091440 A3 WO2012091440 A3 WO 2012091440A3 KR 2011010206 W KR2011010206 W KR 2011010206W WO 2012091440 A3 WO2012091440 A3 WO 2012091440A3
Authority
WO
WIPO (PCT)
Prior art keywords
prevention
improvement
treatment
composition
gastrointestinal motility
Prior art date
Application number
PCT/KR2011/010206
Other languages
French (fr)
Other versions
WO2012091440A2 (en
Inventor
Hee Kyung Jeong
Hee Dong Park
Deok Seong Park
Ki Dong Koo
Chang Hyun Ahn
Original Assignee
Lg Life Sciences Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Life Sciences Ltd. filed Critical Lg Life Sciences Ltd.
Priority to CN2011800636990A priority Critical patent/CN103442726A/en
Publication of WO2012091440A2 publication Critical patent/WO2012091440A2/en
Publication of WO2012091440A3 publication Critical patent/WO2012091440A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/758—Zanthoxylum, e.g. pricklyash
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/20—Agglomerating; Granulating; Tabletting
    • A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

The present invention relates to a composition comprising an extract of Ponciri Fructus and Zanthoxyli Fructus as an active ingredient for improvement, treatment and prevention of gastrointestinal motility disorders. The herb composition of the present invention has a remarkable effect of promoting gasrointestinal motility, thereby being used as a medication or food for improvement, treatment and prevention of gastrointestinal motility disorders.
PCT/KR2011/010206 2010-12-30 2011-12-28 Composition for improvement, treatment and prevention of gastrointestinal motility disorders WO2012091440A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011800636990A CN103442726A (en) 2010-12-30 2011-12-28 Composition for improvement, treatment and prevention of gastrointestinal motility disorders

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20100139064 2010-12-30
KR10-2010-0139064 2010-12-30

Publications (2)

Publication Number Publication Date
WO2012091440A2 WO2012091440A2 (en) 2012-07-05
WO2012091440A3 true WO2012091440A3 (en) 2012-10-04

Family

ID=46383710

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2011/010206 WO2012091440A2 (en) 2010-12-30 2011-12-28 Composition for improvement, treatment and prevention of gastrointestinal motility disorders

Country Status (3)

Country Link
KR (1) KR101444698B1 (en)
CN (1) CN103442726A (en)
WO (1) WO2012091440A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101363311B1 (en) * 2012-02-01 2014-02-17 공주대학교 산학협력단 Zanthoxylum schinifolium extract for prevention and treatment of ulcerative colitis the composition comprising the same
CN103071010B (en) * 2013-01-17 2015-06-17 白长川 Traditional Chinese medicine preparation for treating disorders of gastrointestinal motility
CN104524023A (en) * 2014-12-06 2015-04-22 郭亮 Health care wine for treatment of stomach trouble
CN104435407A (en) * 2014-12-06 2015-03-25 王香平 Medicated wine for treating stomach troubles and preparation method thereof
KR20220151741A (en) 2021-05-07 2022-11-15 충북대학교 산학협력단 Composition comprising Oleoresin Ginger, which are useful for the prevention, improvement or treatment of functional gastrointestinal and motility disorders
KR20230139934A (en) 2022-03-28 2023-10-06 충북대학교 산학협력단 Composition for preventing or treating functional gastrointestinal disorders and gastrointestinal motility disorders comprising oleoresin ginger fraction as an active ingredient
CN115226893A (en) * 2022-07-26 2022-10-25 云南汉木森生物科技有限责任公司 Pepper peel residue and preparation method and application thereof
KR20240029533A (en) 2022-08-26 2024-03-05 가톨릭대학교 산학협력단 Composition for preventing or treating gastrointestinal diseases comprising zanthoxylum piperitum extract
CN116059302B (en) * 2022-12-01 2023-11-10 大连医科大学附属第一医院 Traditional Chinese medicine composition for treating gastrointestinal motility diseases and preparation method and application thereof
WO2024172325A1 (en) * 2023-02-13 2024-08-22 한국과학기술연구원 Composition containing ponciri fructus extract for preventing or treating muscle disease

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998016239A1 (en) * 1996-10-14 1998-04-23 Korea Institute Of Science And Technology CITRUS PEEL EXTRACT AS 3-HYDROXY-3-METHYLGLUTARYL CoA(HMG-CoA) REDUCTASE INHIBITOR
US20020168428A1 (en) * 1999-09-27 2002-11-14 Almada Anthony L. Methods and compositions for reducing sympathomimetic-induced side effects
US20050142074A1 (en) * 2003-12-30 2005-06-30 Council Of Scientific And Industrial Research, Herbal oro-dental care composition and process for preparing the same
US20100104646A1 (en) * 2006-12-28 2010-04-29 Ji Hwal Kim Nanoparticle composition for prevention of hair loss and promotion of hair growth

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08259445A (en) * 1995-01-27 1996-10-08 Takeda Chem Ind Ltd Medicinal composition for improving gastric emptying performance
KR100635658B1 (en) * 2003-07-14 2006-10-18 재단법인서울대학교산학협력재단 Herbal medicinal composition for the treatment of postoperative ileus
CN1846543A (en) * 2005-04-04 2006-10-18 福建南少林药业有限公司 Prepn process of olive granule

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998016239A1 (en) * 1996-10-14 1998-04-23 Korea Institute Of Science And Technology CITRUS PEEL EXTRACT AS 3-HYDROXY-3-METHYLGLUTARYL CoA(HMG-CoA) REDUCTASE INHIBITOR
US20020168428A1 (en) * 1999-09-27 2002-11-14 Almada Anthony L. Methods and compositions for reducing sympathomimetic-induced side effects
US20050142074A1 (en) * 2003-12-30 2005-06-30 Council Of Scientific And Industrial Research, Herbal oro-dental care composition and process for preparing the same
US20100104646A1 (en) * 2006-12-28 2010-04-29 Ji Hwal Kim Nanoparticle composition for prevention of hair loss and promotion of hair growth

Also Published As

Publication number Publication date
WO2012091440A2 (en) 2012-07-05
CN103442726A (en) 2013-12-11
KR101444698B1 (en) 2014-10-07
KR20120090003A (en) 2012-08-16

Similar Documents

Publication Publication Date Title
WO2012091440A3 (en) Composition for improvement, treatment and prevention of gastrointestinal motility disorders
IL236123A0 (en) Compositions comprising n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide for use in the treatment of cftr-mediated disorders
WO2010000877A3 (en) Formulation with irritation reducing action comprising bisabolol and [6]-paradol
WO2012092597A3 (en) Multi-purpose cosmetic compositions
EP2941263A4 (en) A purified extract isolated from pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient, the preparation thereof, and the composition comprising the same as an active ingredient for preventing or treating inflammation, allergy and asthma
WO2012051318A8 (en) Sulphonamide compounds and methods of making and using same
WO2012074930A3 (en) Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
WO2010134756A3 (en) Composition comprising green tea extract
WO2011122869A3 (en) Cosmetic composition comprising coumestrol or a bean extract containing coumestrol for skin care
WO2012046030A3 (en) Phosphodiesterase inhibitors
WO2008007244A3 (en) Composition for improving eye health
WO2010111640A3 (en) Anti-influenza formulations and methods
WO2011059292A3 (en) Aloe vera sprout concentrate or extract having superior skin cell growth promotion, antioxidant, and anti-allergy effects
WO2011122872A3 (en) Composition comprising coumestrol or a bean extract containing coumestrol
WO2011043631A3 (en) Pharmaceutical composition for preventing and treating cold, containing reynoutria elliptica extract, fraction thereof or stilbene-based compound
WO2011141488A3 (en) Pharmaceutical compositions comprising hydromorphone and naloxone
WO2012050398A3 (en) Pharmaceutical composition including herbal medicine extract for preventing or treating lung cancer
EP4331622A3 (en) Integrin binding peptides and uses thereof
WO2012075015A3 (en) Oral metronidazole pharmaceutical compositions
WO2010058982A3 (en) Antioxidant cosmetic composition containing extract of processed peony, polygonati rhizoma or lily
WO2012050397A3 (en) Pharmaceutical composition including herbal medicine extract for preventing or treating kidney cancer
WO2011107866A3 (en) Silyl-derivatives of polysaccharides
WO2013100718A3 (en) Pharmaceutical composition for preventing or treating inflammatory diseases or asthma, containing lagerstroemia ovalifolia extract or fraction thereof as active ingredient
WO2011139249A3 (en) Pharmaceutical composition comprising cefdinir
WO2014133811A3 (en) Compounds from invasive salvinias and methods of using the same

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11853442

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11853442

Country of ref document: EP

Kind code of ref document: A2